Instrument Inactif

Communiqués Canntab Therapeutics Limited

Actions

18/09/23	Canntab Therapeutics Limited Provides Update on Application for Management Cease Trade Order	NE
02/08/22	CANNTAB ANNOUNCES APPOINTMENT OF RICHARD GOLDSTEIN AS INTERIM CEO	PR
30/05/22	CANNTAB ANNOUNCES CHANGE OF AUDITOR	PR
23/03/22	CANNTAB SIGNS AFFILIATE AGRREMENT WITH ONPHARM-UNITED	PR
20/01/22	CANNTAB OFFICIALLY LAUNCHES ITS ONLINE E-COMMERCE PLATFORM	PR
03/03/21	Canntab Fulfills 80% of Its Contract with MediPharm Labs Corp.	NE
17/02/21	Canntab Engages Independent Trading Group for Market Making Services	NE
04/02/21	Canntab Grants Options	NE
31/12/20	Canntab Announces Closing of Convertible Debenture Private Placement	NE
16/11/20	Canntab Therapeutics Announces End of Supply and Distribution Agreements with Exactus	NE
19/10/20	Canntab Announces Closing of Purchases of Cannabis Processing Equipment and Leasehold Improvements	NE
04/03/20	Canntab Announces Cancellation of Options and Issuance of Warrants	NE